莊園牧場(01533.HK):擬向全資子公司瑞嘉牧業增資1.7億元
格隆匯3月5日丨莊園牧場(01533.HK)公佈,董事會審議通過議案,同意公司以自有資金和首次公開發行A股募集資金合計1.7億元向全資子公司瑞嘉牧業增加註冊資本。其中,利用首次公開發行A股募集資金約1.07億元。此次註冊資本增加後,瑞嘉牧業的註冊資本將由1000萬元增加至1.8億元。
此次以A股首發募集資金增加註冊資本部分將按照董事會、股東大會決議通過瑞嘉牧業全部用於“金川區萬頭奶牛養殖循環產業園項目”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.